Is the Party Over for Best-Selling Drug Humira?
Podcast: The Journal.Published On: Thu Feb 09 2023
Description: After decades of patent protection, the wildly successful arthritis and autoimmune drug Humira is finally facing competition. WSJ’s Jared Hopkins on what that could mean for patients and the drug industry. Further Reading: - Blockbuster Arthritis Drug Humira Faces Competition From First Lower-Price Copycat in U.S. - AbbVie Aims for New Drugs to Boost Sales as Competitors Target Humira Further Listening: - How Big Pharma Lost Its Swagger Learn more about your ad choices. Visit megaphone.fm/adchoices
The note was deleted
The note was saved
Your message was sent